These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 20451215

  • 1. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K, Yassouridis A, Mass R, Tenge H, Kellner M, Jahn H, Wiedemann K, Wolf K.
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [Abstract] [Full Text] [Related]

  • 2. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 3. Dose ranging study of the effects of cholecystokinin in healthy volunteers.
    Bradwejn J, Koszycki D, Bourin M.
    J Psychiatry Neurosci; 1991 Jul; 16(2):91-5. PubMed ID: 1911739
    [Abstract] [Full Text] [Related]

  • 4. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R.
    J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
    [Abstract] [Full Text] [Related]

  • 5. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Jan; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity to cholecystokinin-tetrapeptide in major depression.
    Koszycki D, Copen J, Bradwejn J.
    J Affect Disord; 2004 Jun; 80(2-3):285-90. PubMed ID: 15207943
    [Abstract] [Full Text] [Related]

  • 7. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K, Jahn H, Yassouridis A, Kellner M.
    Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
    [Abstract] [Full Text] [Related]

  • 8. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E, Tõru I, Tasa G, Must A, Toover E, Lang A, Vasar V, Shlik J.
    Neurosci Lett; 2008 Dec 03; 446(2-3):88-92. PubMed ID: 18832011
    [Abstract] [Full Text] [Related]

  • 9. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
    Maron E, Tõru I, Vasar V, Shlik J.
    J Psychopharmacol; 2004 Jun 03; 18(2):194-9. PubMed ID: 15260907
    [Abstract] [Full Text] [Related]

  • 10. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.
    Tõru I, Aluoja A, Võhma U, Raag M, Vasar V, Maron E, Shlik J.
    Psychiatry Res; 2010 Jul 30; 178(2):342-7. PubMed ID: 20471107
    [Abstract] [Full Text] [Related]

  • 11. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
    Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demaziere A, Luthringer R, Macher JP.
    Neuroimage; 2006 Jul 01; 31(3):1197-208. PubMed ID: 16600640
    [Abstract] [Full Text] [Related]

  • 12. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J, Koszycki D.
    Scand J Clin Lab Invest Suppl; 2001 Jul 01; 234():19-27. PubMed ID: 11713976
    [Abstract] [Full Text] [Related]

  • 13. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks.
    Eser D, Uhr M, Leicht G, Asmus M, Länger A, Schüle C, Baghai TC, Mulert C, Rupprecht R.
    J Psychiatr Res; 2011 Jan 01; 45(1):60-3. PubMed ID: 20542521
    [Abstract] [Full Text] [Related]

  • 14. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct 01; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 15. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F.
    Int J Neuropsychopharmacol; 2007 Apr 01; 10(2):285-9. PubMed ID: 16817979
    [Abstract] [Full Text] [Related]

  • 16. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA, Koszycki D, Bradwejn J.
    Depress Anxiety; 2004 Apr 01; 20(2):51-8. PubMed ID: 15390214
    [Abstract] [Full Text] [Related]

  • 17. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
    Kellner M, Yassouridis A, Jahn H, Wiedemann K.
    Psychopharmacology (Berl); 1997 Sep 01; 133(1):55-61. PubMed ID: 9335081
    [Abstract] [Full Text] [Related]

  • 18. Effect of oral ondansetron on total cholecystokinin plasma levels following CCK-4 panic challenge procedure in healthy men.
    Dépôt M, Merani S, Bradwejn J, Mukherjee J, Caillé J, Gutkowska J, Caillé G.
    J Psychiatry Neurosci; 1998 Nov 01; 23(5):298-304. PubMed ID: 9846035
    [Abstract] [Full Text] [Related]

  • 19. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rötzer F, Ella R, Möller HJ, Rupprecht R.
    Depress Anxiety; 2003 Nov 01; 18(3):140-3. PubMed ID: 14625878
    [Abstract] [Full Text] [Related]

  • 20. Aging and panicogenic response to cholecystokinin tetrapeptide: an examination of the cholecystokinin system.
    Flint A, Bradwejn J, Vaccarino F, Gutkowska J, Palmour R, Koszycki D.
    Neuropsychopharmacology; 2002 Oct 01; 27(4):663-71. PubMed ID: 12377403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.